Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee

NCT06865079 is registered in ClinicalTrials.gov with OrthoTrophix, Inc as lead sponsor.

NCT NCT06865079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06865079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Severe Tibio- Femoral Osteoarthritis of the Knee
Lead sponsor
OrthoTrophix, Inc
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 9, 2025
Completion date
April 15, 2027
Enrollment
270 (estimated)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis (oa) of the knee